Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...
LOS ANGELES--(BUSINESS WIRE)--BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 ...
CE-marked under the EU IVDR regulation, Diagnostics.AI's platform is the first to deliver AI algorithmic transparency and per-test auditability for clinical PCR diagnostics As the May 26th CE-IVDR ...
Liquid biopsies used to identify and track genetic mutationsin cancer patinets, enabling researchers to detect cancer early, measure therapeutic response, quantify residual tumor burden, and monitor ...
Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years, digital PCR (dPCR) has captured the attention of researchers and clinicians ...
Modifications and adaptations continue to improve how we use PCR, spurring a new level of creativity in genomics hypotheses and enabling a broad versatility in applications. PCR has the speed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results